To provide a mammalian cell suspension capable of preventing formation of pulmonary embolisms when mammalian cells such as mammalian stem cells are administered intraveniously, and a prophylactic agent against the formation of pulmonary embolisms when administering mammalian cells intraveniously.
Mammalian cells suspension for preventing the formation of pulmonary embolisms is prepared, when intraveniously administering mammalian cells, containing mammalian cells and trehalose or derivative thereof or salts of them as effective ingredient, by suspending mammalian cells such as mammalian stem cells in a physiological aqueous solution containing trehalose or derivative thereof or salts of them. As such a mammalian cell, islet cells, dendritic cells, natural killer cells, alpha-beta T cells, gamma-delta T cells and cytotoxic T cells, etc., are cited, and as mammalian stem cells, mammalian mesenchymal stem cells and mammalian pluripotent stem cells can be suitably exemplified.
DOI MASAKO
KIKUCHI KENJI
KOBAYASHI EIJI
| JPH114682A | 1999-01-12 | |||
| JP2012500021A | 2012-01-05 | |||
| JP2009296889A | 2009-12-24 | |||
| JP2009521931A | 2009-06-11 | |||
| JP2010239963A | 2010-10-28 | |||
| JP2012500021A | 2012-01-05 | |||
| JPH114682A | 1999-01-12 | |||
| JP2009296889A | 2009-12-24 | |||
| JP2009521931A | 2009-06-11 | |||
| JP2010239963A | 2010-10-28 |
JPN6013030748; 'Ｊｏｕｒｎａｌ ｏｆ Ｃｅｌｌｕｌａｒ Ｐｈｙｓｉｏｌｏｇｙ' １４．１２．２０１１， Ｖｏｌ．２２７， ｐｐ．８７９-８８４
Seiji Ozawa
Yusaku Tokai
Large High Toshiko
High Kazuya Tsu
Makoto Horiuchi
Next Patent: GREENING STRUCTURE